102 related articles for article (PubMed ID: 16161916)
1. [Is microembolism present and is it important element of COPD exacerbation?].
Karwat K; Kościuch J; Chazan R
Pol Merkur Lekarski; 2005 Apr; 18(106):385-8. PubMed ID: 16161916
[TBL] [Abstract][Full Text] [Related]
2. Effect of corticosteroids on hemostasis and pulmonary arterial pressure during chronic obstructive pulmonary disease exacerbation.
Kunter E; Ilvan A; Ozmen N; Demirer E; Ozturk A; Avsar K; Sayan O; Kartaloğlu Z
Respiration; 2008; 75(2):145-54. PubMed ID: 17143000
[TBL] [Abstract][Full Text] [Related]
3. [Pulmonary embolism and sibilant types of chronic obstructive pulmonary disease decompensations].
Mispelaere D; Glerant JC; Audebert M; Remond A; Sevestre-Pietri MA; Jounieaux V
Rev Mal Respir; 2002 Sep; 19(4):415-23. PubMed ID: 12417857
[TBL] [Abstract][Full Text] [Related]
4. Impact of gastro-oesophageal reflux disease symptoms on COPD exacerbation.
Terada K; Muro S; Sato S; Ohara T; Haruna A; Marumo S; Kinose D; Ogawa E; Hoshino Y; Niimi A; Terada T; Mishima M
Thorax; 2008 Nov; 63(11):951-5. PubMed ID: 18535116
[TBL] [Abstract][Full Text] [Related]
5. Mortality-related factors after hospitalization for acute exacerbation of chronic obstructive pulmonary disease: the burden of clinical features.
Bustamante-Fermosel A; De Miguel-Yanes JM; Duffort-Falcó M; Muñoz J
Am J Emerg Med; 2007 Jun; 25(5):515-22. PubMed ID: 17543654
[TBL] [Abstract][Full Text] [Related]
6. Mean platelet volume is decreased during an acute exacerbation of chronic obstructive pulmonary disease.
Wang RT; Li JY; Cao ZG; Li Y
Respirology; 2013 Nov; 18(8):1244-8. PubMed ID: 23786593
[TBL] [Abstract][Full Text] [Related]
7. [The importance of the at risk COPD patients (Stage 0) and clinical differences].
Kömüs N; Tertemiz KC; Sevinç C
Tuberk Toraks; 2008; 56(4):382-9. PubMed ID: 19123073
[TBL] [Abstract][Full Text] [Related]
8. Postoperative exacerbation of chronic obstructive pulmonary disease. Does it exist?
Leo F; Venissac N; Pop D; Solli P; Filosso P; Minniti A; Radice D; Mouroux J; Spaggiari L; Pastorino U; Jougon J; Velly JF; Oliaro A
Eur J Cardiothorac Surg; 2008 Mar; 33(3):424-9. PubMed ID: 18226541
[TBL] [Abstract][Full Text] [Related]
9. Peripheral arterial disease: an underestimated aetiology of exercise intolerance in chronic obstructive pulmonary disease patients.
Castagna O; Boussuges A; Nussbaum E; Marqueste L; Brisswalter J
Eur J Cardiovasc Prev Rehabil; 2008 Jun; 15(3):270-7. PubMed ID: 18446087
[TBL] [Abstract][Full Text] [Related]
10. Correlates of non-thyroidal illness syndrome in chronic obstructive pulmonary disease.
Karadag F; Ozcan H; Karul AB; Yilmaz M; Cildag O
Respir Med; 2007 Jul; 101(7):1439-46. PubMed ID: 17346957
[TBL] [Abstract][Full Text] [Related]
11. D-dimer levels in stable COPD patients: a case-control study.
Silva DR; Coelho AC; Gazzana MB; Menna Barreto SS; Knorst MM
COPD; 2012 Aug; 9(4):426-31. PubMed ID: 22612665
[TBL] [Abstract][Full Text] [Related]
12. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC
Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
[TBL] [Abstract][Full Text] [Related]
13. The effect of body mass index on functional parameters and quality of life in COPD patients.
Salepçi B; Eren A; Cağlayan B; Fidan A; Torun E; Kiral N
Tuberk Toraks; 2007; 55(4):342-9. PubMed ID: 18224501
[TBL] [Abstract][Full Text] [Related]
14. The role of serum leptin and tumor necrosis factor-alpha in malnutrition of male chronic obstructive pulmonary disease patients.
Yang YM; Sun TY; Liu XM
Chin Med J (Engl); 2006 Apr; 119(8):628-33. PubMed ID: 16635406
[TBL] [Abstract][Full Text] [Related]
15. Nutritional state during COPD exacerbation: clinical and prognostic implications.
Girón R; Matesanz C; García-Río F; de Santiago E; Mancha A; Rodríguez-Salvanés F; Ancochea J
Ann Nutr Metab; 2009; 54(1):52-8. PubMed ID: 19252400
[TBL] [Abstract][Full Text] [Related]
16. Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease.
Hacievliyagil SS; Gunen H; Mutlu LC; Karabulut AB; Temel I
Respir Med; 2006 May; 100(5):846-54. PubMed ID: 16214322
[TBL] [Abstract][Full Text] [Related]
17. Health status impairment and costs associated with COPD exacerbation managed in hospital.
O'Reilly JF; Williams AE; Rice L
Int J Clin Pract; 2007 Jul; 61(7):1112-20. PubMed ID: 17577296
[TBL] [Abstract][Full Text] [Related]
18. Role of arterial blood gas abnormalities in oedema formation in COPD.
Karadag F; Polatli M; Ozcan H; Cildag O
Respirology; 2004 Nov; 9(4):481-4. PubMed ID: 15612959
[TBL] [Abstract][Full Text] [Related]
19. Exacerbations and lung function decline in COPD: new insights in current and ex-smokers.
Makris D; Moschandreas J; Damianaki A; Ntaoukakis E; Siafakas NM; Milic Emili J; Tzanakis N
Respir Med; 2007 Jun; 101(6):1305-12. PubMed ID: 17112715
[TBL] [Abstract][Full Text] [Related]
20. Quality of life during one-year observation of patients with idiopathic pulmonary fibrosis awaiting lung transplantation.
Jastrzebski D; Kozielski J; Banaś A; Cebula T; Gumola A; Ziora D; Krzywiecki A
J Physiol Pharmacol; 2005 Sep; 56 Suppl 4():99-105. PubMed ID: 16204782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
